Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
These reactions typically manifest as mild erythema, swelling, or tenderness at the injection site, usually resolving within 24-48 hours without intervention
Serum levels of vitamin B12 and peripheral blood counts should be monitored in one month
Lightweight, fast-absorbing, and ideal for daily use
The precursor provides raw material for NAD+ synthesis while 5-amino-1mq prevents NNMT from draining the nicotinamide pool
First, it works through a completely different mechanism than stimulants, thermogenics, or GLP-1 based peptides